KFDA to approve Tracleer, a PAH therapy.
Tracleer is an oral endothelin receptor antagonist (ERA), which was developed as the first ERA drug in the world, showing a s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
